IDL Diagnostics: Still under the radar - Redeye

Redeye reviews the case for IDL Diagnostics, and while we down our medium-term sales forecasts, we reconsider our long-term estimates. We lengthen our DCF period ending in 2035e (from 2032e) and assume higher market penetrations for its key products.

Länk till analysen i sin helhet: https://www.redeye.se/research/1124765/idl-diagnostics-still-under-the-radar?utm_source=finwire&utm_medium=RSS